Huang W, Cao Q, Lu Y
Shanghai Institute of Hematology, Shanghai Ruijin Hospital, Shanghai Second Medical University.
Zhonghua Yi Xue Za Zhi. 1994 Nov;74(11):662-5, 708.
By using "nested" retrotranscriptase/polymerase chain reaction (RT/PCR) technique, we determined the expression patterns of the BCR-ABL fusion gene resulting from the chromosomal translocation t (9; 22) in leukemias with Ph1 chromosome. Three distinct isoforms of fusion gene transcripts were discovered: ela2, b2a2 and b3a2. In 10 cases of chronic myelogenous leukemia (CML), only two types (b2a2 and b3a2) were observed. However, in 8 cases of Ph1 chromosome positive acute lymphoblastic leukemia (Ph1 + ALL), all three types were detected, including two cases characterized by the coexistence of ela2 and b2a2 or b3a2 types. Moreover, the RT/PCR procedure established in the present study proved to be a very sensitive method, allowing the detection of one leukemic cell among 10(5)-10(6) normal cells. Thus, a positive RT/PCR result was obtained in two Ph1 + ALL cases just after chemotherapy-induced clinical remission (CR), suggesting the presence of residual disease. One case remained RT/PCR positive four months after achieving CR and relapsed in the fifth month, while the other case converted to RT/PCR negative eight months later and is now in CR for 18 months. Therefore the detection of BCR-ABL fusion gene is of importance not only in the study of the pathogenesis of Ph1 + leukemias but also in their diagnosis and monitoring of minimal residual disease during CR.
通过使用“巢式”逆转录酶/聚合酶链反应(RT/PCR)技术,我们确定了在具有Ph1染色体的白血病中由染色体易位t(9;22)产生的BCR-ABL融合基因的表达模式。发现了融合基因转录本的三种不同异构体:ela2、b2a2和b3a2。在10例慢性粒细胞白血病(CML)中,仅观察到两种类型(b2a2和b3a2)。然而,在8例Ph1染色体阳性急性淋巴细胞白血病(Ph1+ALL)中,检测到了所有三种类型,包括两例以ela2与b2a2或b3a2类型共存为特征的病例。此外,本研究建立的RT/PCR程序被证明是一种非常敏感的方法,能够在10(5)-10(6)个正常细胞中检测到一个白血病细胞。因此,在两例Ph1+ALL病例化疗诱导临床缓解(CR)后立即获得了阳性RT/PCR结果,提示存在残留疾病。一例在达到CR后四个月RT/PCR仍为阳性,并在第五个月复发,而另一例在八个月后转为RT/PCR阴性,目前处于CR状态18个月。因此,检测BCR-ABL融合基因不仅在Ph1+白血病的发病机制研究中具有重要意义,而且在其诊断以及CR期间微小残留疾病的监测中也具有重要意义。